$AMRN
AMARIN CORP PLC\UK Stock $amrn

$amrn Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000095017022014008 Filed on August 03, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$94.44M	$94.63M	$144.5M
YoY Change	-38.87%	-33.44%	-13.61%
Cost Of Revenue	$35.81M	$22.24M	$30.64M
YoY Change	11.37%	-21.49%	-11.89%
Gross Profit	$43.63M	$72.39M	$113.9M
YoY Change	-64.34%	-36.41%	-14.06%
Gross Profit Margin	46.2%	76.5%	78.8%
Selling, General & Admin	$86.89M	$90.65M	$92.37M
YoY Change	-18.95%	-14.32%	-20.93%
% of Gross Profit	199.16%	125.22%	81.13%
Research & Development	$9.356M	$10.05M	$5.753M
YoY Change	47.18%	7.19%	-32.39%
% of Gross Profit	21.44%	13.88%	5.05%
Depreciation & Amortization	$781.0K	$780.0K	$781.0K
YoY Change	-0.51%	52.64%	52.84%
% of Gross Profit	1.79%	1.08%	0.69%
Operating Expenses	$106.5M	$100.7M	$98.12M
YoY Change	-6.25%	-12.57%	-21.71%
Operating Profit	-$62.83M	-$28.31M	$15.74M
YoY Change	-816.2%	2026.75%	119.82%
Interest Expense	$288.0K	$203.0K	$172.0K
YoY Change	1.05%	-56.9%	-55.67%
% of Operating Profit			1.09%
Other Income/Expense, Net	-$2.255M	-$246.0K	$88.00K
YoY Change	1080.63%	73.24%	62.96%
Pretax Income	-$64.80M	-$28.35M	$16.39M
YoY Change	-830.79%	2729.34%	115.7%
Income Tax	$5.157M	$3.213M	$1.695M
% Of Pretax Income			10.34%
Net Earnings	-$69.96M	-$31.56M	$14.70M
YoY Change	-995.95%	1841.14%	198.38%
Net Earnings / Revenue	-74.07%	-33.35%	10.17%
Basic Earnings Per Share	-$0.18	-$0.08
Diluted Earnings Per Share	-$0.18	-$0.08	$34.76K
COMMON SHARES
Basic Shares Outstanding	398.2M	397.8M
Diluted Shares Outstanding	398.2M	397.8M

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$313.2M	$362.6M	$454.1M
YoY Change	-38.45%	-29.56%	-9.34%
Cash & Equivalents	$228.0M	$219.2M	$219.5M
Short-Term Investments	$85.23M	$143.4M	$234.7M
Other Short-Term Assets	$36.18M	$32.01M	$26.27M
YoY Change	11.85%	-4.77%	-24.65%
Inventory	$225.8M	$267.8M	$234.7M
Prepaid Expenses
Receivables	$143.9M	$110.2M	$163.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$719.1M	$772.6M	$878.7M
YoY Change	-27.8%	-16.97%	-0.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.137M	$1.281M	$1.425M
YoY Change	-33.63%	-86.96%	-29.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$11.40M	$26.70M	$35.00M
YoY Change	-19.52%	11.24%	-43.98%
Other Assets	$456.0K	$456.0K	$456.0K
YoY Change	0.0%	0.0%	5.56%
Total Long-Term Assets	$254.1M	$201.1M	$189.3M
YoY Change	418.57%	236.29%	118.16%
TOTAL ASSETS
Total Short-Term Assets	$719.1M	$772.6M	$878.7M
Total Long-Term Assets	$254.1M	$201.1M	$189.3M
Total Assets	$973.2M	$973.7M	$1.068B
YoY Change	-6.87%	-1.68%	10.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$116.3M	$90.75M	$114.9M
YoY Change	-17.66%	-3.72%	8.54%
Accrued Expenses	$243.1M	$207.6M	$253.1M
YoY Change	7.29%	-9.23%	27.42%
Deferred Revenue	$2.198M	$2.198M	$2.649M
YoY Change	-16.84%		-9.47%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$361.6M	$300.6M	$370.7M
YoY Change	-2.39%	-7.73%	20.57%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.636M	$7.490M	$7.648M
YoY Change	38.13%	-74.93%	23.08%
Total Long-Term Liabilities	$7.636M	$7.490M	$7.648M
YoY Change	38.13%	-74.93%	23.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$361.6M	$300.6M	$370.7M
Total Long-Term Liabilities	$7.636M	$7.490M	$7.648M
Total Liabilities	$393.2M	$332.6M	$401.0M
YoY Change	-1.62%	-6.48%	18.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.523B	-$1.453B	-$1.421B
YoY Change	7.03%		-0.54%
Common Stock	$294.7M	$294.4M	$294.0M
YoY Change	0.64%		1.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$61.42M	$61.26M	$60.73M
YoY Change	4.08%		18.88%
Treasury Stock Shares	$7.709M	$7.648M	$7.487M
Shareholders Equity	$580.0M	$641.1M	$667.1M
YoY Change
Total Liabilities & Shareholders Equity	$973.2M	$973.7M	$1.068B
YoY Change	-6.87%	-1.67%	10.56%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	-$69.96M	-$31.56M	$14.70M
YoY Change	-995.95%	1841.14%	198.38%
Depreciation, Depletion And Amortization	$781.0K	$780.0K	$781.0K
YoY Change	-0.51%	52.64%	52.84%
Cash From Operating Activities	-$64.58M	-$98.85M	-$28.24M
YoY Change	329.04%	428.48%	-26.31%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$73.19M	$99.05M	$25.02M
YoY Change	44.5%	-22.58%	5.62%
Cash From Investing Activities	$73.19M	$99.05M	$25.02M
YoY Change	44.5%	-22.58%	5.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	244.0K	-505.0K	-196.0K
YoY Change	-42.72%	-90.28%	-96.5%
NET CHANGE
Cash From Operating Activities	-64.58M	-98.85M	-28.24M
Cash From Investing Activities	73.19M	99.05M	25.02M
Cash From Financing Activities	244.0K	-505.0K	-196.0K
Net Change In Cash	8.850M	-303.0K	-3.420M
YoY Change	-75.43%	-100.29%	-83.11%
FREE CASH FLOW
Cash From Operating Activities	-$64.58M	-$98.85M	-$28.24M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7865000
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.amarincorp.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
	dei	Entity Central Index Key EntityCentralIndexKey	0000897448
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Registrant Name EntityRegistrantName	AMARIN CORP PLC\UK
	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-21392
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	X0
	dei	Entity Address Address Line1 EntityAddressAddressLine1	77 Sir John Rogerson’s Quay
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Block C
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Grand Canal Docklands
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	2
	dei	Entity Address Country EntityAddressCountry	IE
	dei	City Area Code CityAreaCode	353 (0) 1
	dei	Local Phone Number LocalPhoneNumber	6699 020
	dei	Security12b Title Security12bTitle	American Depositary Shares (ADS(s)), each ADSrepresenting the right to receive one (1) Ordinary Share ofAmarin Corporation plc
	dei	Trading Symbol TradingSymbol	AMRN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	228001000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	219454000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3918000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3918000
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	85232000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	234674000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-575000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	404084775
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	396598008
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	294659000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022Q2	us-gaap	Inventory Net InventoryNet	225772000
CY2021Q4	us-gaap	Inventory Net InventoryNet	234676000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32259000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	294027000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1869770000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5157000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143942000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	163653000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1059000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	405056452
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	397347051
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22352000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	719124000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	878727000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1137000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1425000
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	11395000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	34996000
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	210252000
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	121254000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8599000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7660000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	456000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	456000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22274000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23547000
CY2022Q2	us-gaap	Assets Assets	973237000
CY2021Q4	us-gaap	Assets Assets	1068065000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	116312000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	114922000
CY2022Q2	amrn	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	243064000
CY2021Q4	amrn	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	253111000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2198000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2649000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	361574000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	370682000
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	13810000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	14060000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10174000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8576000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7636000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7648000
CY2022Q2	us-gaap	Liabilities Liabilities	393194000
CY2021Q4	us-gaap	Liabilities Liabilities	400966000
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1855246000
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	7709401
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7486767
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	61419000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	60726000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1522967000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8370000
	amrn	Cost Of Goods And Services Sold Restructuring Inventory CostOfGoodsAndServicesSoldRestructuringInventory	15000000
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2255000
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-191000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8867000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1421448000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	580043000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	667099000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	973237000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1068065000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	94440000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	154488000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	189070000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	296658000
CY2022Q2	us-gaap	Cost Direct Material CostDirectMaterial	35810000
CY2021Q2	us-gaap	Cost Direct Material CostDirectMaterial	32155000
	us-gaap	Cost Direct Material CostDirectMaterial	58049000
	us-gaap	Cost Direct Material CostDirectMaterial	60481000
CY2022Q2	amrn	Cost Of Goods And Services Sold Restructuring Inventory CostOfGoodsAndServicesSoldRestructuringInventory	15000000
CY2022Q2	us-gaap	Gross Profit GrossProfit	43630000
CY2021Q2	us-gaap	Gross Profit GrossProfit	122333000
	us-gaap	Gross Profit GrossProfit	116021000
	us-gaap	Gross Profit GrossProfit	236177000
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	86893000
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	107203000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	177540000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	213001000
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9356000
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6357000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19407000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15734000
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	10213000
	us-gaap	Restructuring Charges RestructuringCharges	10213000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	106462000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	113560000
	us-gaap	Operating Expenses OperatingExpenses	207160000
	us-gaap	Operating Expenses OperatingExpenses	228735000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-62832000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	8773000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-91139000
	us-gaap	Operating Income Loss OperatingIncomeLoss	7442000
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	288000
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	285000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	491000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	756000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2501000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-333000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64799000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	75000
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-677000
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-93149000
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2479000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	7808000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1683000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-69956000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	634611000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	398187000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	395899000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	397997000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	395272000
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1028000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	7808000
	us-gaap	Net Income Loss NetIncomeLoss	-101519000
	us-gaap	Net Income Loss NetIncomeLoss	6182000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	398187000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	401767000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	397997000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	402778000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	667099000
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30000
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-535000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6078000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-31563000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	641109000
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	383000
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19000
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-158000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8646000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-69956000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	580043000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	627505000
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2059000
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-7252000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13925000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1626000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	645324000
	us-gaap	Profit Loss ProfitLoss	-101519000
	us-gaap	Profit Loss ProfitLoss	6182000
	amrn	Depreciation And Amortization Excluding Amortization Of Intangible Assets DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets	288000
	amrn	Depreciation And Amortization Excluding Amortization Of Intangible Assets DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets	299000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	330933000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2112000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-773000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3711000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-8657000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	51279000
	amrn	Initial Recognition Of Operating Lease Right Of Use Asset InitialRecognitionOfOperatingLeaseRightOfUseAsset	1052000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	647000
	amrn	Non Cash Or Part Non Cash Milestone Payment NonCashOrPartNonCashMilestonePayment	12000000
CY2022Q2	us-gaap	Assets Assets	973200000
CY2022Q2	amrn	Cash And Liquid Short Term And Long Term Investments CashAndLiquidShortTermAndLongTermInvestments	324600000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1126000
	us-gaap	Share Based Compensation ShareBasedCompensation	14724000
	us-gaap	Share Based Compensation ShareBasedCompensation	16404000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1273000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	997000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-19711000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27685000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	80094000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83591000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9907000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2521000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	24000
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-229000
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-672000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-701000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1164000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-163431000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33757000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	186411000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	253084000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14172000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	74510000
	amrn	Disposal Purchase Of Furniture Fixtures And Equipment DisposalPurchaseOfFurnitureFixturesAndEquipment	4000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	172239000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	178578000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	383000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1028000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	49000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2134000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	693000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7929000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-261000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4767000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8547000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	140054000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	223372000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	190879000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	231919000
CY2022Q2	amrn	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-69956000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	719100000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	228000000.0
CY2021Q2	amrn	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	7808000
	amrn	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-101519000
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	10213000
CY2021Q4	amrn	Valuation Allowances Provisions And Reserves Balance Net ValuationAllowancesProvisionsAndReservesBalanceNet	280693000
	amrn	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	6182000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	398187000
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	85200000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143900000
CY2022Q2	us-gaap	Inventory Net InventoryNet	225800000
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	11400000
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	210300000
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	395899000
	amrn	Accounts Receivable Credit Period AccountsReceivableCreditPeriod	P30D
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	189782000
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	262948000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143942000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	163653000
	us-gaap	Restructuring Charges RestructuringCharges	10213000
CY2022Q2	amrn	Cost Of Goods And Services Sold Restructuring Inventory CostOfGoodsAndServicesSoldRestructuringInventory	15000000
	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	398246000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	397997000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	395272000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	398187000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	401767000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	397997000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	402778000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:13.5pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term and long-term investments, and accounts receivable. The Company maintains substantially all of its cash and cash equivalents and short-term and long-term investments, in financial institutions believed to be of high-credit quality.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">A significant portion of the Company’s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> customers individually accounted for 10% or more of the Company’s gross product sales, Customers A, B, and C accounted for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">38</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">31</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of gross product sales for the six months ended June 30, 2022, and represented </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">41</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of the gross accounts receivable balance as of June 30, 2022. Customers A, B, and C accounted for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">27</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">36</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of gross product sales for the six months ended June 30, 2021 and represented </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">34</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of the gross accounts receivable balance as of June 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company has not experienced any significant write-offs of its accounts receivable. All customer accounts are actively managed and no losses in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">excess </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">of amounts reserved are currently expected; however, the Company is monitoring the potential negative impact of COVID-19 on the Company’s customers’ ability to meet their financial obligations.</span></p>
	amrn	Cost Of Goods And Services Sold Restructuring Inventory CostOfGoodsAndServicesSoldRestructuringInventory	15000000
CY2022Q2	amrn	Restructuring Charges Includes Cost Of Goods Sold Restructuring Inventory RestructuringChargesIncludesCostOfGoodsSoldRestructuringInventory	25213000
	amrn	Restructuring Charges Includes Cost Of Goods Sold Restructuring Inventory RestructuringChargesIncludesCostOfGoodsSoldRestructuringInventory	25213000
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P24M
CY2022Q2	amrn	Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue	900000
CY2021Q2	amrn	Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue	100000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021Q3	amrn	Number Of Sales Representatives NumberOfSalesRepresentatives	300
CY2021Q3	amrn	Number Of Sales Representatives NumberOfSalesRepresentatives	300
CY2022Q2	amrn	Number Of Sales Representatives NumberOfSalesRepresentatives	75
CY2022Q2	amrn	Employee Restructuring Separation Charges EmployeeRestructuringSeparationCharges	9123000
	amrn	Employee Restructuring Separation Charges EmployeeRestructuringSeparationCharges	9123000
CY2022Q2	amrn	Vendor Contract Charges VendorContractCharges	1090000
	amrn	Vendor Contract Charges VendorContractCharges	1090000
	amrn	Provision Related To Prior Period Sales ProvisionRelatedToPriorPeriodSales	-107000
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	271693000
	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	454000
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	22915000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	41965000
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	240309000
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	1186000
	amrn	Restructuring Costs Incurred RestructuringCostsIncurred	25213000
	us-gaap	Payments For Restructuring PaymentsForRestructuring	3938000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y9M18D
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32081000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32081000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9807000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8534000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22274000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23547000
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	132687000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	107695000
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	63028000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	206270000
CY2022Q2	amrn	Inventory Current And Non Current InventoryCurrentAndNonCurrent	436024000
CY2021Q4	amrn	Inventory Current And Non Current InventoryCurrentAndNonCurrent	355930000
CY2022Q2	amrn	Finished Goods Deemed Not Saleable FinishedGoodsDeemedNotSaleable	9600000
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	210300000
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	121300000
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	81500000
CY2022Q2	amrn	Communication Costs Pertaining To Marketing Commitments CommunicationCostsPertainingToMarketingCommitments	600000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25247
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	810459
	amrn	Proceeds From Stock Options Exercised Gross ProceedsFromStockOptionsExercisedGross	49000
	amrn	Proceeds From Stock Options Exercised Gross ProceedsFromStockOptionsExercisedGross	2134000
	amrn	Credits Payments Made For Prior Period Sales CreditsPaymentsMadeForPriorPeriodSales	214794000
CY2022Q2	amrn	Valuation Allowances Provisions And Reserves Balance Net ValuationAllowancesProvisionsAndReservesBalanceNet	192559000
CY2020Q4	amrn	Valuation Allowances Provisions And Reserves Balance Net ValuationAllowancesProvisionsAndReservesBalanceNet	190827000
	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	409766000
	amrn	Provision Related To Prior Period Sales ProvisionRelatedToPriorPeriodSales	854000
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	212807000
	amrn	Credits Payments Made For Prior Period Sales CreditsPaymentsMadeForPriorPeriodSales	168242000
CY2021Q2	amrn	Valuation Allowances Provisions And Reserves Balance Net ValuationAllowancesProvisionsAndReservesBalanceNet	218690000
	us-gaap	Revenue Practical Expedient Financing Component RevenuePracticalExpedientFinancingComponent	true
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16709000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	701000
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16008000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18632000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	662000
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17970000
	amrn	Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod	701000
	amrn	Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod	662000
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.115
	amrn	Operating Lease Change In Weighted Average Discount Rate Percent OperatingLeaseChangeInWeightedAverageDiscountRatePercent	0.01
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	11200000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10300000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8600000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7700000
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	600000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	400000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2089000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2124000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1120000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2247000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2150000
CY2022Q2	amrn	Lessee Operating Lease Liability Payments Due Year Five And Thereafter LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter	7212000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	16942000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5738000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1030000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10174000

Files In Submission

Name	View Source	Status
0000950170-22-014008-index-headers.html	Edgar Link	pending
0000950170-22-014008-index.html	Edgar Link	pending
0000950170-22-014008.txt	Edgar Link	pending
0000950170-22-014008-xbrl.zip	Edgar Link	pending
amrn-20220630.htm	Edgar Link	pending
amrn-20220630.xsd	Edgar Link	pending
amrn-20220630_cal.xml	Edgar Link	unprocessable
amrn-20220630_def.xml	Edgar Link	unprocessable
amrn-20220630_htm.xml	Edgar Link	completed
amrn-20220630_lab.xml	Edgar Link	unprocessable
amrn-20220630_pre.xml	Edgar Link	unprocessable
amrn-ex10_2.htm	Edgar Link	pending
amrn-ex10_3.htm	Edgar Link	pending
amrn-ex10_4.htm	Edgar Link	pending
amrn-ex10_5.htm	Edgar Link	pending
amrn-ex31_1.htm	Edgar Link	pending
amrn-ex31_2.htm	Edgar Link	pending
amrn-ex32_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img151388582_0.jpg	Edgar Link	pending
img196694077_0.jpg	Edgar Link	pending
img198541119_0.jpg	Edgar Link	pending
img198541119_1.jpg	Edgar Link	pending
img199464640_0.jpg	Edgar Link	pending
img199464640_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMRN
AMARIN CORP PLC\UK Stock $amrn

2022 Q2 Form 10-Q Financial Statement

#000095017022014008 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRN AMARIN CORP PLC\UK Stock $amrn

2022 Q2 Form 10-Q Financial Statement

#000095017022014008 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRN
AMARIN CORP PLC\UK Stock $amrn